Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Food and Drug Administration is correcting a notice entitled "Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments" that appeared in the Federal Register of April 11, 2023. The document announced a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee. The document was published with the incorrect docket number. This document corrects that error.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 75 (Wednesday, April 19, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 75 (Wednesday, April 19, 2023)]
[Notices]
[Page 24191]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-08279]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2023-N-1338]
Vaccines and Related Biological Products Advisory Committee;
Notice of Meeting; Establishment of a Public Docket; Request for
Comments; Correction
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; establishment of a public docket; request for comments;
correction.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration is correcting a notice
entitled ``Vaccines and Related Biological Products Advisory Committee;
Notice of Meeting; Establishment of a Public Docket; Request for
Comments'' that appeared in the Federal Register of April 11, 2023. The
document announced a forthcoming public advisory committee meeting of
the Vaccines and Related Biological Products Advisory Committee. The
document was published with the incorrect docket number. This document
corrects that error.
FOR FURTHER INFORMATION CONTACT: Lisa Granger, Office of Policy,
Planning, Legislation and International Affairs, Food and Drug
Administration, 301-796-9115, <a href="/cdn-cgi/l/email-protection#feb2978d9fd0b98c9f90999b8cbe989a9fd096968dd0999188"><span class="__cf_email__" data-cfemail="8ac6e3f9eba4cdf8ebe4edeff8caeceeeba4e2e2f9a4ede5fc">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: In the Federal Register of Tuesday, April
11, 2023 (88 FR 21688) in FR Doc. 2023-248, the following corrections
are made:
1. On page 21688, in the third column, in the header of the
document, ``Docket No. FDA-2023-N-0378'' is corrected to read ``Docket
No. FDA-2023-N-1338'' and in the ADDRESSES section, in the third line
of the last paragraph, ``FDA-2023-N-0378'' is corrected to read ``FDA-
2023-N-1338.''
2. On page 21689, in the first column, in the second line of the
``Instructions:'' section, Docket No. FDA-2023-N-0378'' is corrected to
read ``Docket No. FDA-2023-N-1338''.
Dated: April 14, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023-08279 Filed 4-18-23; 8:45 am]
BILLING CODE 4164-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.